Moderna, Inc.

Halal Rating :
See Details
Last Price $131.88 Last updated:
Market Cap $58.06b
7D Change -1.55%
1 Year Change -1.55%

Company Overview

  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing
Exchange NASDAQ
Next Earnings Date Feb. 22, 2024

Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2024 $167.0m $1.78b $120.0m $6.0m 71.86% 0.34%
Dec. 31, 2023 $2.75b $5.09b $103.0m $6.0m 3.74% 0.12%
Sept. 30, 2023 $1.8b $4.29b $105.0m $10.0m 5.84% 0.23%

Company Impact

Help us evaluate Moderna, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates